Oct 6 (Reuters) - Aroa Biosurgery Ltd (ARX) :
- H1 FY22 PRODUCT SALES REVENUE OF ABOUT NZ$17 MILLION, GROWTH OF 108%
- SIGNED A CONTRACT EXTENSION FOR ITS MYRIAD PRODUCTS WITH HEALTHTRUST
- SEES FY22 PRODUCT SALES REVENUE AT UPPER END OF PREVIOUSLY ANNOUNCED GUIDANCE OF NZ$30 MILLION TO NZ$33 MILLION
Oct 6 (Reuters) - Aroa Biosurgery Ltd (ARX) : H1 FY22 PRODUCT...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
-0.005(0.81%) |
Mkt cap ! $210.4M | |||
| Open | High | Low | Value | Volume |
| 62.5¢ | 62.5¢ | 60.5¢ | $101.9K | 165.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7000 | 60.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.5¢ | 3169 | 1 |
View Market Depth
| Last trade - 16.10pm 11/08/2025 (20 minute delay) ? |
| ARX (ASX) Chart |